000 01416 a2200361 4500
005 20250515053102.0
264 0 _c20070503
008 200705s 0 0 eng d
022 _a0934-9723
024 7 _a10.1007/s10096-006-0247-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKafetzis, D A
245 0 0 _aSafety and tolerability of clarithromycin administered to children at higher-than-recommended doses.
_h[electronic resource]
260 _bEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
_cFeb 2007
300 _a99-103 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdolescent
650 0 4 _aAnti-Bacterial Agents
_xadministration & dosage
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aClarithromycin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aGreece
650 0 4 _aHumans
650 0 4 _aInfant
650 0 4 _aMale
650 0 4 _aRespiratory Tract Infections
_xdrug therapy
700 1 _aChantzi, F
700 1 _aTigani, G
700 1 _aSkevaki, C L
773 0 _tEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
_gvol. 26
_gno. 2
_gp. 99-103
856 4 0 _uhttps://doi.org/10.1007/s10096-006-0247-3
_zAvailable from publisher's website
999 _c16781916
_d16781916